CluePoints Study Links Risk-Based Trial Oversight to Faster Drug Development
WAYNE, PA — Clinical trial sponsors using risk-based quality management (RBQM) may shorten oncology trial timelines by as much as 19% while generating returns of up to 23 times their …
CluePoints Study Links Risk-Based Trial Oversight to Faster Drug Development Read More